ATA New 2014 Treatment Guidelines Reviewed By Mary Shomon

Mary Shomon has written a good review of the new treatment guidelines by the American Thyroid Association. She also has a link so you can download a copy. ATA has codified somatoform disorder into the new guidelines which I think will turn out to be a nightmare for many patients. Although they have incorporated a lot of the current science into their discussion there is little change in the guidelines from previous versions. PR

Last edited by

5 Replies

  • I'm surprised and disappointed that Shomon hasn't commented on the references to somatoform disorder.

  • humanbean I agree, I was surprised she didn't catch that item. Apparently some of us are attuned to the possible dangers involved, i.e. more referrals to a shrink, the trashcan of medicine. PR

  • HB, somatoform disorder is diagnosed when T4 monotherapy doesn't relieve symptoms. As the benefits of T3 and NDT are "unknown", ie not adequately double blind random controlled researched, confirmation bias towards T4 is entrenched despite anecodotal evidence that T3 and NDT may, and do, alleviate symptoms.

  • But why didn't Shomon mention it? It is a surprising omission, given that she has covered it before, and clearly wasn't impressed :

    Making a diagnosis of somatoform disorder "official" and putting it in the guidelines just means that more thyroid patients will be ignored, have their lives ruined, and will be tossed in the dustbin, with a mental health diagnosis of hypochondria on their medical records.

    If someone gets that diagnosis they can almost wave goodbye to a job if any potential employers see that. If I was an employer I would be reluctant to employ a known hypochondriac.

  • HB, yes she clearly wasn't impressed with Weetman's somataform theory.

You may also like...